Tadayyon M - Search Results

1

Minireview: Challenges and opportunities in development of PPAR agonists.

Wright MB, Bortolini M, Tadayyon M, Bopst M. Wright MB, et al. Among authors: tadayyon m. Mol Endocrinol. 2014 Nov;28(11):1756-68. doi: 10.1210/me.2013-1427. Epub 2014 Aug 22. Mol Endocrinol. 2014. PMID: 25148456 Free PMC article. Review.

2

Fatty acids inhibit leptin signalling in BRIN-BD11 insulinoma cells.

Briscoe CP, Hanif S, Arch JR, Tadayyon M. Briscoe CP, et al. Among authors: tadayyon m. J Mol Endocrinol. 2001 Apr;26(2):145-54. doi: 10.1677/jme.0.0260145. J Mol Endocrinol. 2001. PMID: 11241166

3

Leptin receptor long-form signalling in a human liver cell line.

Briscoe CP, Hanif S, Arch JR, Tadayyon M. Briscoe CP, et al. Among authors: tadayyon m. Cytokine. 2001 May 21;14(4):225-9. doi: 10.1006/cyto.2001.0871. Cytokine. 2001. PMID: 11448122

4

Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats.

Al-Barazanji KA, Arch JR, Buckingham RE, Tadayyon M. Al-Barazanji KA, et al. Among authors: tadayyon m. Obes Res. 2000 Jul;8(4):317-23. doi: 10.1038/oby.2000.38. Obes Res. 2000. PMID: 10933308 Free article.

5

Effect of chronic central infusion of murine and human leptin in lean Zucker rats.

Al-Barazanji KA, Buckingham RE, Tadayyon M, Arch JR. Al-Barazanji KA, et al. Among authors: tadayyon m. Int J Obes Relat Metab Disord. 2000 Jun;24 Suppl 2:S127-8. doi: 10.1038/sj.ijo.0801298. Int J Obes Relat Metab Disord. 2000. PMID: 10997629 No abstract available.

6

Anti-obesity drugs: a critical review of current therapies and future opportunities.

Clapham JC, Arch JR, Tadayyon M. Clapham JC, et al. Among authors: tadayyon m. Pharmacol Ther. 2001 Jan;89(1):81-121. doi: 10.1016/s0163-7258(00)00105-4. Pharmacol Ther. 2001. PMID: 11316515 Review.

7

Effects of chronic murine and human leptin infusion on plasma leptin and corticosterone levels and energy balance in lean Zucker rats.

Al-Barazanji KA, Buckingham RE, Arch JR, Briscoe C, Jenkins O, Tadayyon M. Al-Barazanji KA, et al. Among authors: tadayyon m. Diabetes Obes Metab. 2001 Dec;3(6):435-42. doi: 10.1046/j.1463-1326.2001.00162.x. Diabetes Obes Metab. 2001. PMID: 11903416

8

Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat.

Haynes AC, Jackson B, Overend P, Buckingham RE, Wilson S, Tadayyon M, Arch JR. Haynes AC, et al. Among authors: tadayyon m. Peptides. 1999;20(9):1099-105. doi: 10.1016/s0196-9781(99)00105-9. Peptides. 1999. PMID: 10499428

9

Hypothalamic orexin expression: modulation by blood glucose and feeding.

Cai XJ, Widdowson PS, Harrold J, Wilson S, Buckingham RE, Arch JR, Tadayyon M, Clapham JC, Wilding J, Williams G. Cai XJ, et al. Among authors: tadayyon m. Diabetes. 1999 Nov;48(11):2132-7. doi: 10.2337/diabetes.48.11.2132. Diabetes. 1999. PMID: 10535445

10

A selective orexin-1 receptor antagonist reduces food consumption in male and female rats.

Haynes AC, Jackson B, Chapman H, Tadayyon M, Johns A, Porter RA, Arch JR. Haynes AC, et al. Among authors: tadayyon m. Regul Pept. 2000 Dec 22;96(1-2):45-51. doi: 10.1016/s0167-0115(00)00199-3. Regul Pept. 2000. PMID: 11102651

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters